Drugs Industry | featured news

CVS Caremark Corp. says it will pay $1.25 billion to Universal American Corp. for its Medicare prescription drug services unit.

J&J agreed to buy an 18.4% stake in Elan for $1 billion and acquire the rights to much of the Irish biotech company's research into drugs for Alzheimer's disease.

One of the drug industry's most renowned names is having a lot of trouble landing new drugs.

Pfizer Inc. is unveiling a new program Thursday that will let people who have lost their jobs and health insurance keep taking some widely prescribed Pfizer medications - including Lipitor and Viagra - for free for up to a year.

Walgreen profit fell 6.7% as sales outside of the pharmacy department slipped. Discounts dented profit margins.

Deal talks between Genentech and Roche hit a snag over dueling interpretations of arcane SEC rules, but the problem is unlikely to derail the transaction, according to people familiar with the matter.

Dow Chemical and Rohm & Haas have reached a tentative deal to complete their disputed $15 billion merger, according to people briefed on the situation.

Drugmakers Merck & Co. and Schering-Plough Corp. are planning to merge under the name Merck in a stock-and-cash deal worth about $41.1 billion.

Swiss drug company Roche Holding increased its offer to acquire the rest of Genentech to $93 a share from $86.50.

Walgreen Co. executives are considering selling booze at its drugstores after phasing out beer and wine at all but a few hundred stores in the 1990s.